Andromeda Rico

Dr. Andromeda Rico

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in American Journal of Physiology-Gastrointestinal and Liver Physiology
Verified
Journal Article
Open access
LRLuis M. Ramírez-Maldonado
Luis M. Ramírez-Maldonado
JGJulio Guerrero-Castro
Julio Guerrero-Castro
JRJosé L. Rodríguez-Mejía
José L. Rodríguez-Mejía
YCYair Cárdenas-Conejo
Yair Cárdenas-Conejo
EBEdgar O. Bonales-Alatorre
Edgar O. Bonales-Alatorre
ARAndromeda Rico
Andromeda Rico
The gut microbiota changes gradually following the consumption of CAF diet. An increase in Clostridia and Proteobacteria is a hallmark of dysbiosis at the early onset of gut inflammation and obesity. The CAF diet was effective in inducing intestinal low-grade inflammation and alterations in myenteric neuronal excitability in mice. CAF diet is a reliable strategy to study the interplay between gut dysbiosis and low-grade inflammation, in addition to the mechanisms underlying gastrointestinal dysmotility associated with obesity.

8 April 2024 in Purinergic Signalling
Verified
Journal Article
Closed access
PDF file
JCJosé R. Cruz-Muñoz
José R. Cruz-Muñoz
EVEduardo E. Valdez-Morales
Eduardo E. Valdez-Morales
ABAlma Barajas-Espinosa
Alma Barajas-Espinosa
TBTonatiuh Barrios-García
Tonatiuh Barrios-García
ARAndromeda Rico
Andromeda Rico
RGRaquel Guerrero-Alba
Raquel Guerrero-Alba

28 September 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
GGGuillermo Alejandro Cabral García
Guillermo Alejandro Cabral García
JCJosé R. Cruz-Muñoz
José R. Cruz-Muñoz
EVEduardo Valdez-morales
Eduardo Valdez-morales
ABAlma Barajas-Espinosa
Alma Barajas-Espinosa
ARAndromeda Rico
Andromeda Rico
RGRaquel Guerrero-Alba
Raquel Guerrero-Alba
The role of P2X ionotropic receptors in the behavior of purinergic signaling on pathophysiological processes has been widely studied. In recent years, the important participation of P2X receptors in physiological and pathological processes, such as energy metabolism, characteristic inflammatory responses of the immune system, and nociceptive activity in response to pain stimuli, has been noted. Here, we explore the molecular characteristics of the P2X receptors and the use of the different agonist and antagonist agents recently described, focusing on their potential as new therapeutic targets in the treatment of diseases with emphasis on obesity, diabetes, and some of the complications derived from these pathologies.

22 June 2025 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
GCGUILLERMO A. CABRAL-GARCÍA
GUILLERMO A. CABRAL-GARCÍA
ECEstefanía G. Contreras‐Vázquez
Estefanía G. Contreras‐Vázquez
ARAndromeda Rico
Andromeda Rico
ABAlma Barajas-Espinosa
Alma Barajas-Espinosa
FOFernando Ochoa‐Cortes
Fernando Ochoa‐Cortes
RGRaquel Guerrero‐Alba
Raquel Guerrero‐Alba